NCT05920252 A Digitally Assisted Risk Reduction Platform for Youth at High Risk for Suicide
| NCT ID | NCT05920252 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ksana Health |
| Condition | Suicide |
| Study Type | INTERVENTIONAL |
| Enrollment | 78 participants |
| Start Date | 2024-08-14 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 78 participants in total. It began in 2024-08-14 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Despite efforts to prevent suicide, US rates are climbing, and suicide is the second leading cause of death among youth. Digital tools, especially personal smartphones, are promising avenues to address these issues and can be used to provide a unique understanding of risk factors, including psychological distress, anhedonia and behavioral withdrawal, and sleep disturbance among high-risk individuals. This project aims to enhance the effectiveness of the delivery of preventative health care to youth at risk for suicide by developing a comprehensive digital platform that allows practitioners to integrate mobile sensing data and HIPAA-compliant client communication tools into their management of these young people.
Eligibility Criteria
Inclusion Criteria: * Written informed assent from adolescents ages 13-17 years old and permission from legal guardians, or consent from adolescents age 18 years old. * Receiving treatment at the Intensive Adolescent and Family DBT Pgogram * 13-18 years old * Owns a personal smartphone (Android or iPhone 7+) * Fluent in English Exclusion Criteria: * Adolescents who require a higher level of care (i.e., are not admitted to the Intensive Outpatient DBT program) * Adolescents who are receiving treatment at the Intensive Adolescent and Family DBT program and have already been assigned a clinician
Contact & Investigator
Nick Allen, PhD
PRINCIPAL INVESTIGATOR
Ksana Health
Frequently Asked Questions
Who can join the NCT05920252 clinical trial?
This trial is open to participants of all sexes, aged 13 Years or older, up to 18 Years, studying Suicide. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05920252 currently recruiting?
Yes, NCT05920252 is actively recruiting participants. Contact the research team at rpa2009@cumc.columbia.edu for enrollment information.
Where is the NCT05920252 trial being conducted?
This trial is being conducted at New York, United States.
Who is sponsoring the NCT05920252 clinical trial?
NCT05920252 is sponsored by Ksana Health. The principal investigator is Nick Allen, PhD at Ksana Health. The trial plans to enroll 78 participants.